RT Journal Article
SR Electronic
T1 Multi-site disease analytics with applications to estimating COVID-19 undetected cases in Canada
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.07.11.22277508
DO 10.1101/2022.07.11.22277508
A1 Parker, Matthew R. P.
A1 Cao, Jiguo
A1 Cowen, Laura L. E.
A1 Elliott, Lloyd T.
A1 Ma, Junling
YR 2022
UL http://medrxiv.org/content/early/2022/07/12/2022.07.11.22277508.abstract
AB Even with daily case counts, the true scope of the COVID-19 pandemic in Canada is unknown due to undetected cases. We estimate the pandemic scope through a new multi-site model using publicly available disease count data including detected cases, recoveries among detected cases, and total deaths. These counts are used to estimate the case detection probability, the infection fatality rate through time, as well as the probability of recovery, and several important population parameters including the rate of spread, and importation of external cases. We also estimate the total number of active COVID-19 cases per region of Canada for each reporting interval. We applied this multi-site model Canada-wide to all provinces and territories, providing an estimate of the total COVID-19 burden for the 90 weeks from 23 Apr 2020 to 6 Jan 2022. We also applied this model to the five Health Authority regions of British Columbia, Canada, describing the pandemic in B.C. over the 31 weeks from 2 Apr 2020 to 30 Oct 2020.Competing Interest StatementThe authors have declared no competing interest.Funding StatementLC was supported by a Michael Smith Foundation for Health Research and Victoria Hospitals Foundation Grant #COV-2020-1061 and a Canadian Statistical Sciences Institute Rapid Response Program: COVID-19.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Data was downloaded from publicly available government sources: BCCDC (Weekly Surveillance Reports), PHAC (COVID-19 epidemiology update), and Yukon Health (COVID-19 Dashboard Data). Data used has been archived here: https://github.com/mrparker909/COVID-MultiSiteModel2022.gitI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are available online at: https://github.com/mrparker909/COVID-MultiSiteModel2022.git https://github.com/mrparker909/COVID-MultiSiteModel2022.git